Drug major Lupin today said it has received approval from its shareholders to raise up to Rs 7,500 crore through issue of securities.
In a BSE filing, the Mumbai-based firm said shareholders have approved a proposal today “to raise funds for an amount not exceeding Rs 7,500 crore through issue of securities“.
The shareholders also approved reappointment of Desh Bandhu Gupta as Executive Chairman of the company for five years with effect from January 1, 2016, it added.
The members also approved reappointment of Kamal K Sharma as Vice Chairman of the company for a period of two years, with effect from September 29, 2015.
Last month the company’s board had given in-principle approval for raising funds of up to Rs 7,500 crore and now shareholders in the annual general meeting (AGM) have approved the fund raising exercise.
The filing, however, did not disclose the purpose of raising the funding.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.